Test Price
2,400 AED✅ Home Collection Available
Hepatitis C Virus (HCV) Qualitative PCR & Genotyping Combo in UAE
Executive Summary & Core Metrics
- ✓ Diagnostic Accuracy: 99.9% sensitivity via ISO‑accredited real‑time PCR and Sanger sequencing for definitive HCV RNA detection and genotype identification.
- ✓ Premium Logistics: VIP mobile phlebotomy and temperature‑controlled cold‑chain home collection available daily from 8 AM to 11 PM.
- ✓ Clinical Support: Complimentary telephonic post‑test guidance provided by a DHA‑licensed general practitioner.
- ✓ Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The HCV Qualitative PCR & Genotyping Combo detects the presence of hepatitis C virus RNA and simultaneously identifies the viral genotype (1 through 6) using a validated two‑step molecular workflow. Real‑time PCR provides qualitative detection with greater than 99.9% sensitivity, while Sanger sequencing of the 5′ untranslated region and core region resolves the genotype with high discriminatory power. This combined approach is the recommended first‑line molecular strategy for patients with confirmed reactive serology or clinical suspicion of chronic HCV infection.
| Feature | Our Test (DNA Labs UAE) | Closest Alternative |
|---|---|---|
| Method | Real‑Time PCR + Sanger Sequencing | HCV Antibody (serology) |
| Diagnostic Sensitivity | >99.9% | ~95% (may miss early or seronegative infection) |
| Genotype Information | Yes (full genotype 1–6 report) | Not available |
| Turnaround Time | 5 working days | 1–2 days (antibody only) |
| Specimen Matrix | Peripheral blood / Plasma / Serum | Serum |
Physician Insight & Safety Protocols
“A positive HCV RNA result must always be interpreted alongside liver function tests and the patient’s clinical history. Genotyping is not optional — it directly determines the selection and duration of direct‑acting antiviral therapy. Patients should review their complete laboratory profile with a treating specialist before any treatment decision is made.”
— Dr. Ajay Singh, General Practitioner, DHA Registration ID: 36234132
Medication Safety Advisory
Do not discontinue, alter, or interrupt any prescribed hepatitis C antiviral medication without explicit instruction from your managing physician. Abrupt cessation of direct‑acting antiviral therapy may lead to the emergence of drug‑resistant viral variants and compromise future treatment options. If you experience any adverse effects, contact your healthcare provider immediately rather than stopping the medication on your own.
Exclusion Criteria & Emergency Red Flags
- Exclusion from home collection: Active major bleeding, severe uncorrected coagulopathy, inability to provide informed consent, or age under 18 years without a legally authorised guardian present (in accordance with Federal Decree‑Law No. 4 of 2016 on Medical Liability).
- Seek immediate emergency care if you experience: new‑onset jaundice, confusion or altered mental status, haematemesis, severe right upper quadrant abdominal pain, or any signs suggestive of hepatic encephalopathy.
Patient FAQ & Clinical Guidance
1. What is the HCV Qualitative PCR & Genotyping Combo test?
This single‑workflow molecular assay detects hepatitis C virus RNA in the blood to confirm active infection and simultaneously identifies the specific viral genotype (1 through 6). The genotype result is essential for selecting the most effective direct‑acting antiviral regimen and predicting treatment duration.
2. How accurate is this test compared to standard antibody screening?
The combo test delivers greater than 99.9% diagnostic sensitivity for HCV RNA detection using ISO‑accredited real‑time PCR technology, with genotype identification confirmed by Sanger sequencing. Antibody tests alone cannot distinguish between active and past infection and offer no genotypic information.
3. Do I need to stop my current medications before providing a blood sample?
No. The test does not require fasting, special dietary preparation, or interruption of any prescribed medication. However, please inform the phlebotomist if you are taking anticoagulant therapy so that appropriate post‑puncture care can be arranged.
UAE Regulatory & Data Privacy Adherence
Data Protection & Health Information Governance
- All personal data and health information are processed in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Electronic health record handling and clinical data security follow the requirements of Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Patient consent, clinical safety, and medical liability are governed by Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Laboratory Certification & Facility Credentials
- DHA Facility License Number: 1143
- Location: Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE
- Corporate Lab Branding: DNA Labs UAE
- All molecular assays are performed under ISO‑accredited quality management protocols with stringent internal and external quality control programmes.
Clinical & Logistical Metadata
| Test Name | Hepatitis C Virus (HCV) Qualitative PCR & Genotyping Combo |
| Price (AED) | 2,400 AED |
| Turnaround Time | 5 working days from sample receipt |
| Sample Type / Matrix | Peripheral whole blood, Plasma, or Serum |
| Methodology Used | Real‑Time PCR (qualitative detection) followed by Sanger sequencing (genotype identification) |
| ICD-10-CM Code | B18.2 (Chronic viral hepatitis C) |
| LOINC Code | 20416-4 |
| DHA Facility License & Laboratory Address | License 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians